Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models.

classification head and neck squamous cell carcinomas human papilloma virus machine learning metastasis radiomics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Jul 2021
Historique:
received: 18 04 2021
revised: 07 07 2021
accepted: 20 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 8 8 2021
Statut: epublish

Résumé

Current radiomic studies of head and neck squamous cell carcinomas (HNSCC) are typically based on datasets combining tumors from different locations, assuming that the radiomic features are similar based on histopathologic characteristics. However, molecular pathogenesis and treatment in HNSCC substantially vary across different tumor sites. It is not known if a statistical difference exists between radiomic features from different tumor sites and how they affect machine learning model performance in endpoint prediction. To answer these questions, we extracted radiomic features from contrast-enhanced neck computed tomography scans (CTs) of 605 patients with HNSCC originating from the oral cavity, oropharynx, and hypopharynx/larynx. The difference in radiomic features of tumors from these sites was assessed using statistical analyses and Random Forest classifiers on the radiomic features with 10-fold cross-validation to predict tumor sites, nodal metastasis, and HPV status. We found statistically significant differences (

Identifiants

pubmed: 34359623
pii: cancers13153723
doi: 10.3390/cancers13153723
pmc: PMC8345201
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Contrast Media Mol Imaging. 2018 Sep 27;2018:3574310
pubmed: 30363632
Oncology. 2015;89(3):125-36
pubmed: 25967534
Neuroimaging Clin N Am. 2020 Nov;30(4):433-445
pubmed: 33038994
Neuroimaging Clin N Am. 2020 Nov;30(4):517-529
pubmed: 33039001
Sci Rep. 2020 Mar 2;10(1):3852
pubmed: 32123281
Br J Radiol. 2018 Jun;91(1086):20170498
pubmed: 29451412
PLoS One. 2019 Sep 19;14(9):e0222509
pubmed: 31536526
Sci Rep. 2021 Apr 15;11(1):8262
pubmed: 33859265
EBioMedicine. 2019 Jul;45:70-80
pubmed: 31255659
J Clin Oncol. 2009 Apr 20;27(12):1992-8
pubmed: 19289615
J Surg Oncol. 2019 Dec 3;:
pubmed: 31797378
Br J Radiol. 2020 Feb 1;93(1106):20190496
pubmed: 31682155
Sci Rep. 2019 Feb 26;9(1):2764
pubmed: 30809047
Eur Radiol. 2019 Nov;29(11):6172-6181
pubmed: 30980127
Front Oncol. 2021 Mar 29;11:633176
pubmed: 33854969
Sci Rep. 2018 Jan 24;8(1):1524
pubmed: 29367653
J Surg Oncol. 2014 Oct;110(5):551-74
pubmed: 25053506
Radiology. 2017 Sep;284(3):748-757
pubmed: 28493790
Strahlenther Onkol. 2019 Sep;195(9):805-818
pubmed: 31222468
Oral Oncol. 2017 Aug;71:150-155
pubmed: 28688683
Nat Rev Cancer. 2018 May;18(5):269-282
pubmed: 29497144
Oral Oncol. 2019 Aug;95:178-186
pubmed: 31345388
Eur Radiol. 2020 Feb;30(2):833-843
pubmed: 31673835
Eur J Radiol. 2019 Jan;110:1-6
pubmed: 30599844
Front Oncol. 2019 Mar 27;9:174
pubmed: 30972291
Front Oncol. 2019 Aug 30;9:821
pubmed: 31544063
J Digit Imaging. 2020 Jun;33(3):613-618
pubmed: 31950301
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
Phys Med Biol. 2019 Mar 29;64(7):075011
pubmed: 30780137

Auteurs

Xiaoyang Liu (X)

Princess Margaret Hospital, University of Toronto, University Health Network, Toronto, ON M5G 2C1, Canada.
Department of Radiology, Brigham and Women's Hospital, Harvard University, Cambridge, MA 02115, USA.
Department of Medical Imaging, University of Toronto, Toronto, ON M5S 1A1, Canada.

Farhad Maleki (F)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.

Nikesh Muthukrishnan (N)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.

Katie Ovens (K)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.

Shao Hui Huang (SH)

Princess Margaret Hospital, University of Toronto, University Health Network, Toronto, ON M5G 2C1, Canada.
Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5S 1A1, Canada.

Almudena Pérez-Lara (A)

Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Griselda Romero-Sanchez (G)

Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Sahir Rai Bhatnagar (SR)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC H3A 1A2, Canada.

Avishek Chatterjee (A)

Medical Physics Unit, McGill University, Montreal, QC H3A 1A2, Canada.

Marc Philippe Pusztaszeri (MP)

Division of Pathology, Jewish General Hospital, Montreal, QC H3Y 1E2, Canada.

Alan Spatz (A)

Division of Pathology, Jewish General Hospital, Montreal, QC H3Y 1E2, Canada.

Gerald Batist (G)

Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Seyedmehdi Payabvash (S)

Section of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06520, USA.

Stefan P Haider (SP)

Section of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06520, USA.

Amit Mahajan (A)

Section of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06520, USA.

Caroline Reinhold (C)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.

Behzad Forghani (B)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.
Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Brian O'Sullivan (B)

Princess Margaret Hospital, University of Toronto, University Health Network, Toronto, ON M5G 2C1, Canada.
Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5S 1A1, Canada.

Eugene Yu (E)

Princess Margaret Hospital, University of Toronto, University Health Network, Toronto, ON M5G 2C1, Canada.
Department of Medical Imaging, University of Toronto, Toronto, ON M5S 1A1, Canada.

Reza Forghani (R)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology and the Research Institute of the McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.
Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Classifications MeSH